Chongqing Zhifei Biological Products Co., Ltd.: Tuberculosis trials
The registry lists 17 Tuberculosis studies with Chongqing Zhifei Biological Products Co., Ltd. as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 7Phase 2 4Phase 3 4Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02329730Phase 2Results posted
- Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT01999231Phase 1Results posted
- C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in IndonesiaCompletedNCT07587164Not applicable
- Phase II Clinical Clical of the Pure Protein Derivatives of BCGCompletedNCT06975774Phase 1
- Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion ProteinCompletedNCT05746611Phase 4
- A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)SuspendedNCT05284812Phase 2
- Phase I Clinical Protocol of BCG-PPD in Healthy PeopleCompletedNCT04593771Phase 1
- Clinical Study of BCG Vaccine for Intradermal InjectionCompletedNCT04563273Phase 1
- Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis PatientsActive, not recruitingNCT04538911Phase 1
- A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)CompletedNCT04239313Phase 1
- Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for ChildrenCompletedNCT03027154Phase 3
- A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-driedCompletedNCT03026972Phase 1
- Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)CompletedNCT02795260Phase 3
- Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 AllergenCompletedNCT02623556Phase 3
- Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65CompletedNCT02389322Phase 2
- Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02336542Phase 2
- Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent TuberculosisCompletedNCT01979900Phase 3